Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced, NSCLC and Urothelial Cancer

Condition:   Unresectable Non-small Cell Lung Cancer (NSCLC) and Urothelial Cancer Intervention:   Drug: Durvalumab Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials